Human Centriole and Centrosome Antibody IgG ELISA Kit |
|
MBS039049-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Human IgG antibody Laboratories manufactures the genomeweb seracare immunotherapy reagents distributed by Genprice. The Genomeweb Seracare Immunotherapy reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SeraCare Inc.. Other Genomeweb products are available in stock. Specificity: Genomeweb Category: Seracare Group: Immunotherapy
Human True insulin ELISA kit |
|
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human True insulin ELISA kit |
|
BlueGene |
96T |
EUR 700 |
|
Description: ELISA |
Human True Insulin ELISA Kit |
|
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Human True Insulin ELISA Kit |
|
MyBiosource |
48-Strip-Wells |
EUR 550 |
Human True Insulin ELISA Kit |
|
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Human True Insulin ELISA Kit |
|
MyBiosource |
96-Strip-Wells |
EUR 765 |
Human True Insulin GENLISA ELISA |
|
Krishgen |
1 x 96 wells |
EUR 286 |
Immunotherapy information
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target) |
|
MBS4380957-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target) |
|
MBS4380958-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target) |
|
MBS4380958-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target) |
|
MBS4380958-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target) |
|
MBS4380958-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target) |
|
MBS4380958-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target) |
|
MBS4380959-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target) |
|
MBS4380959-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target) |
|
MBS4380959-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target) |
|
MBS4380959-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target) |
|
MBS4380959-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target) |
|
MBS4380960-05mL |
MyBiosource |
0.5mL |
EUR 405 |
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target) |
|
MBS4380960-5x05mL |
MyBiosource |
5x0.5mL |
EUR 1725 |
MAGE-1 (Target for Cancer Immunotherapy); Clone MA454 (Concentrate) |
|
RA0201-C.1 |
ScyTek Laboratories |
0.1 ml |
EUR 60.07 |
MAGE-1 (Target for Cancer Immunotherapy); Clone MA454 (Concentrate) |
|
RA0201-C.5 |
ScyTek Laboratories |
0.5 ml |
EUR 200.66 |
MAGE-1 (Target for Cancer Immunotherapy); Clone SPM282 (Concentrate) |
|
RA0576-C.1 |
ScyTek Laboratories |
0.1 ml |
EUR 60.07 |
MAGE-1 (Target for Cancer Immunotherapy); Clone SPM282 (Concentrate) |
|
RA0576-C.5 |
ScyTek Laboratories |
0.5 ml |
EUR 200.66 |
